2019
DOI: 10.1016/j.biocel.2019.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Chalcone derivatives as non-canonical ligands of TRPV1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 57 publications
0
9
0
Order By: Relevance
“…TRPV1 may be activated by various ligands, including derivates of ployunsaturated fatty acids, oxytocin, neurotransmitters, chalcone derivatives, and cannabinoids (42)(43)(44)(45)(46). Cannabinoids are of particular interest, as they have demonstrated some similarities to capsaicin in regard to their anti-inflammatory and anti-tumoral effects in various organs, albeit some of these are mediated by specific receptors (47).…”
Section: Capsaicin and Its Receptor In The Pulmonary Systemmentioning
confidence: 99%
“…TRPV1 may be activated by various ligands, including derivates of ployunsaturated fatty acids, oxytocin, neurotransmitters, chalcone derivatives, and cannabinoids (42)(43)(44)(45)(46). Cannabinoids are of particular interest, as they have demonstrated some similarities to capsaicin in regard to their anti-inflammatory and anti-tumoral effects in various organs, albeit some of these are mediated by specific receptors (47).…”
Section: Capsaicin and Its Receptor In The Pulmonary Systemmentioning
confidence: 99%
“…Along with their role as molecular sensors in the nociceptive pathway, evidence indicates that TRPV1 channels have a broad physiological function, underscoring their importance in pharmacology and biomedicine. , In contrast to commercially available drugs targeting the inflammatory system, TRPV1 antagonists act as critical negative modulators of nociceptive transduction . Moreover, TRPV1 activation is followed by nerve inactivation, ,, making both potent agonists and antagonists viable tools to promote the desired analgesic effect, provided the necessary pharmacokinetic characteristics are favorable. , In this context, the naturally occurring molecules capsaicin (CAP) and resiniferatoxin (RTx) are well-described vanilloid ligands acting as potent TRPV1 agonists. , On the other hand, capsazepine (CPZ), a synthetic derivative of CAP, is an inhibitor of TRPV1 activity. , All three have inhibited nociceptive neuron firing in vitro and in vivo . Thus, targeting TRPV1 channel activity presents an attractive approach to pain relief that may qualify as the next generation of analgesics. ,, …”
Section: Introductionmentioning
confidence: 99%
“…21,22,29 In this context, small molecules from the secondary metabolism of land plants containing groups similar to those on the CAP's head appear to provide a modular scaffold helpful for the straightforward design of potent and selective ligands for TRPV1. 27,28 Ideal for drug design, CAP's head derivatives are well recognized for the easiness of incorporation into pharmacophores, facilitating repurposing while keeping significant water solubility. 30,31 Here, we aimed to find an economic computational pipeline to combine physicochemical data from in silico analysis with useful pharmacological descriptors.…”
Section: Introductionmentioning
confidence: 99%
“…In capsaicin and natural capsaicin‐like compounds, vanillyl was identified as an essential group to modulate TRPV1. Subsequently, a wide number of TRVP1 ligands have been synthesised that have other groups instead of vanillyl, such as pyrimidine 16 , 2-benzothiazolyl acetamide 17 , catechol 18 , 19 , chalcone 20 , 2–(3-fluoro-4-methylsulfonylaminophenyl)propanamide 21 , etc.…”
Section: Introductionmentioning
confidence: 99%